|
Pharmaceutical company Novartis will build and operate its first Texas radioligand therapy, or RLT, manufacturing plant in Denton on Shady Oaks Drive, according to a news release from the company. The site will be fully operational in 2028.
Some background: Denton City Council approved an economic development agreement with the company in December. Construction is expected to begin at the ned of this year, according to the release.
The new facility will produce drugs for radioligand therapy, a form of targeted radiation used to treat advanced forms of cancer, according to the Novartis website. In the treatment, a tumor-seeking molecule, or ligand, is combined with a radioactive isotope and delivers direct radiation to cancer cells.
The Denton location will be the fifth manufacturing site of its kind in the United States, the release states.
The impact: The plant will be a 46,000-square-foot facility and is part of the company's $23 billion investment in the United States. The new plant will create local jobs in bioengineering, advanced manufacturing, quality and operations.
|